CM
CBAY

Crestline Management’s Cymabay Therapeutics CBAY Stock Holding History

Crestline Management’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-104,392
Closed -$841K – 213
2017
Q3 		$841K Buy
+104,392
New +$841K 0.12% 107